NaviFUS
Phase 2- Indications
- Drug-resistant epilepsy, Brain cancer, Alzheimer's disease
Company intelligence / Profile preview
Genovate-NaviFUS
Melbourne, Victoria, Australianavifus.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
The company has completed Phase 1 safety trials in rGBM showing safe and reversible BBB opening. Ongoing clinical trials include epilepsy treatment in Australia and Alzheimer’s disease therapy. The technology enables non-invasive BBB opening to enhance CNS drug delivery or direct neuromodulation. Early results indicate safety and feasibility with ongoing efficacy studies
- Therapeutic areas
- OncologyPsychiatryNeurology
- Modalities
- DeviceBiologic (for drug delivery facilitation)Small molecule (as part of combination therapies)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Bracco Imaging S.p.A. (ultrasound imaging agents)UniPharma (distribution partner)Academic hospitals such as Alfred Hospital/Melbourne & Chang Gung Memorial Hospital Linkou
Beyond the preview
Go deeper on Genovate-NaviFUS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genovate-NaviFUS.